Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 19 Feb 2024 · doblin-0266
Quote
Not a forecast
“We're also starting research in Europe. So we're trying to get approval by the European Medicines Agency. So we're doing studies in around 10 sites and 7 countries in Europe.”
Doblin states that MAPS is running European trials at about 10 sites in 7 countries with the aim of EMA approval of MDMA-assisted therapy. No date is attached.
Descriptive, retrospective, or a statement of preference; no future state asserted.